Mgo One Seven LLC Mesoblast LTD Transaction History

Mgo One Seven LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 09, 2019	SELL	$4.19 - $5.25 $838 - $1,050	-200 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$3.51 - $8.6 $702 - $1,720	200 New	200 $0
Q3 2018 Oct 09, 2018	SELL	$5.75 - $8.16 $1,150 - $1,632	-200 Closed	0 $0
Q4 2017 Feb 16, 2018	BUY	$4.91 - $7.23 $982 - $1,446	200	200 $1,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $1.57B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

Stay updated on Mgo One Seven LLC with notifications on news.